Ypsomed Holding AG (SWX:YPSN)

Revenue by Segment

Financials in millions CHF. Fiscal year is April - March.

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017
Period Ending	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021	Mar 31, 2020	Mar 31, 2019	Mar 31, 2018	Mar 31, 2017
Eliminations	-16.89M	-16.87M	-4.35M	-2.21M	-1.87M
Others	71.16M	96.17M	16.60M	18.33M	20.19M
Others Growth	-26.01%	479.19%	-9.42%	-9.19%	24.43%
Ypsomed Delivery Systems	601.55M	502.27M	385.15M	307.81M	259.04M
Ypsomed Delivery Systems Growth	19.77%	30.41%	25.13%	18.83%	22.66%
Ypsomed Diabetes Care	75.16M	167.30M	151.05M	173.53M	187.49M
Ypsomed Diabetes Care Growth	-55.07%	10.76%	-12.96%	-7.45%	5.49%
Total	730.98M	748.87M	548.46M	497.46M	464.84M
Total Growth	-2.39%	36.54%	10.25%	7.02%	15.16%

Revenue by Geography

Financials in millions CHF. Fiscal year is April - March.

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017
Period Ending	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021	Mar 31, 2020	Mar 31, 2019	Mar 31, 2018	Mar 31, 2017
Switzerland	107.59M	88.85M	58.01M	60.80M	42.43M
Switzerland Growth	21.09%	53.16%	-4.59%	43.31%	20.13%
Europe	401.53M	446.75M	332.59M	308.88M	296.63M
Europe Growth	-10.12%	34.33%	7.68%	4.13%	10.11%
North America	64.64M	56.55M	47.51M	39.81M	41.19M
North America Growth	14.31%	19.03%	19.33%	-3.35%	4.99%
Others	157.23M	156.72M	110.35M	87.97M	84.60M
Others Growth	0.33%	42.02%	25.44%	3.99%	41.65%
Total	730.98M	748.87M	548.46M	497.46M	464.84M
Total Growth	-2.39%	36.54%	10.25%	7.02%	15.16%

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every six months for this company.

Update frequency:

Semi-annually

Last checked:

Jun 21, 2026

Data Sources Report a data error